NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+5.74%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.25B
AUM Growth
+$2.25B
(-6.9%)
Cap. Flow
+$58.4M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
71.88%
Holding
46
New
3
Increased
7
Reduced
–
Closed
3
Top Buys
1 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$26.3M |
2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$14.7M |
3 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$14.6M |
4 |
CRISPR Therapeutics
CRSP
|
$12.1M |
5 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$10.6M |
Top Sells
1 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$33.5M |
2 |
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
|
$1.97M |
3 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$478K |
Sector Composition
1 | Healthcare | 87.61% |
2 | Technology | 5.47% |